1,913 results on '"Lindor, Keith"'
Search Results
2. The Power of Rotation Schedules on the Career Selection Decisions of Medical Students
3. Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis
4. Serum miRNA profiles are altered in patients with primary sclerosing cholangitis receiving high-dose ursodeoxycholic acid
5. Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis
6. Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA
7. Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?
8. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
9. Cancer risk in primary sclerosing cholangitis: Epidemiology, prevention, and surveillance strategies
10. Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe
11. Dominant strictures in primary sclerosing cholangitis: A multicenter survey of clinical definitions and practices
12. Primary Sclerosing Cholangitis, Part 2: Cancer Risk, Prevention, and Surveillance.
13. Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis
14. Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
15. Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis
16. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis
17. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis
18. Successful response of primary sclerosing cholangitis and associated ulcerative colitis to oral vancomycin may depend on brand and personalized dose: report in an adolescent
19. Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis
20. The long-term outcomes of patients with immunoglobulin G4-related sclerosing cholangitis: the Mayo Clinic experience
21. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis: Expert Review
22. Effects of Age and Sex of Response to Ursodeoxycholic Acid and Transplant-free Survival in Patients With Primary Biliary Cholangitis
23. Simplified care-pathway selection for nonspecialist practice: the GLOBAL Primary Biliary Cholangitis Study Group Age, Bilirubin, Alkaline phosphatase risk assessment tool
24. An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort
25. Emerging therapies for PBC
26. Machine Learning-based Development and Validation of a Scoring System for Screening High-Risk Esophageal Varices
27. Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis
28. Characteristics and Outcomes Reported by Patients With Primary Sclerosing Cholangitis Through an Online Registry
29. Autoimmune Liver Diseases: Primary Biliary Cholangitis
30. Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis
31. Antimitochondrial Antibody–Negative Primary Biliary Cholangitis: Is It Really the Same Disease?
32. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment
33. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems
34. Increased Waitlist Mortality and Lower Rate for Liver Transplantation in Hispanic Patients With Primary Biliary Cholangitis
35. Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival
36. Curcumin in Hepatobiliary Disease: Pharmacotherapeutic Properties and Emerging Potential Clinical Applications
37. Data from Ulcerative Colitis–Associated Colorectal Cancer Arises in a Field of Short Telomeres, Senescence, and Inflammation
38. Supplementary Figures 1-2, Table 1 from Ulcerative Colitis–Associated Colorectal Cancer Arises in a Field of Short Telomeres, Senescence, and Inflammation
39. Recurrence of Primary Sclerosing Cholangitis After Liver Transplantation
40. Advances in primary sclerosing cholangitis
41. Oral tolerance and pyruvate dehydrogenase in patients with primary biliary cirrhosis.
42. Letter to the Editor: Insurance should cover vancomycin for primary sclerosing cholangitis
43. Ursodeoxycholic acid treatment-induced GLOBE score changes are associated with liver transplantation-free survival in patients with primary biliary cholangitis
44. Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls
45. Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitis
46. Primary Sclerosing Cholangitis: Clinical and Systemic Manifestations and Treatment
47. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’
48. Primary biliary cirrhosis
49. Ursodeoxycholic Acid Treatment--Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
50. Commentary: Primary Sclerosing Cholangitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.